VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
IOSPInnospec Inc.
$82.63$2.0B
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
HomeStocksIOSPCash Flow

Innospec Inc. (IOSP) Cash Flow Statement

28Y historyFree accessUpdated daily

Cash flow conversion remains volatile, with the operating cash flow to net income ratio swinging from 0.15 in 2024Q2 to 3.05 in 2025Q3, reflecting significant working capital instability.

IOSP Cash Flow Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricTTMDec'25Dec'24Dec'23Dec'22Dec'21Dec'20Dec'19Dec'18Dec'17Dec'16Dec'15Dec'14Dec'13Dec'12Dec'11Dec'10Dec'09Dec'08Dec'07Dec'06Dec'05Dec'04Dec'03Dec'02Dec'01Dec'00Dec'99Dec'98
Cash from Operations127.6M138.3M184.5M207.3M81.7M93.2M145.9M161.6M104.9M82.7M104.5M117.7M106.3M61.3M61.3M34.7M58.2M87.4M14.4M47.9M36.4M43.8M62.4M85.2M100M90M134M108.7M238.3M
Operating CF Margin %-7.78%10%10.64%4.16%6.28%12.23%10.68%7.1%6.33%11.83%11.63%11.06%7.49%7.9%4.48%8.52%14.6%2.25%7.95%6.84%8.3%12.99%18.43%22.15%21.38%31.72%21.03%51.25%
Operating CF Growth %152.44%-25.04%-11%153.73%-12.34%-36.12%-9.72%54.05%26.84%-20.86%-11.21%10.72%73.41%0%76.66%-40.38%-33.41%506.94%-69.94%31.59%-16.89%-29.81%-26.76%-14.8%11.11%-32.84%23.28%-54.39%-
Net Income114.2M116.6M35.6M139.1M133M93.1M28.7M112.2M85M61.8M81.3M119.5M84.1M77.8M68.3M48.9M73.7M6.4M12.5M29.5M11.4M-123.7M6.2M51.8M52.1M5.6M18.3M42.6M70.4M
Depreciation & Amortization42.6M43.6M43.5M39.3M40.1M42.7M46M47.6M49.6M50.4M38.1M35.2M29.1M20.4M11.5M14.4M15.4M18.4M23M31.3M27.4M28.7M24.4M25.8M32.4M87.2M80.2M68.4M59.7M
Stock-Based Compensation4.1M8.1M8.5M8M6.7M4.4M5.8M26.7M4.9M4.1M3.3M3.7M2.6M2.5M3.1M3.1M800K1.5M1.6M3.3M1.6M00000000
Deferred Taxes-300K-10.2M-39.3M3.6M-5.5M6.4M-2.5M05.5M-6.7M900K12M5.8M5.8M12.6M-4M-15M14.1M-1.1M-4.6M-2M-5M-800K5M1.6M-800K5.2M14.5M1.5M
Other Non-Cash Items-12.1M-19.8M155.1M-3.3M-2.5M-5.3M17.8M-4.1M-5.3M-1.9M-16.3M-51.3M-15.1M-15.5M-15.4M15.6M-7.5M-26.7M-5.5M2.5M16.6M16.6M-13.8M2M4.6M18.2M2M-1.2M-900K
Working Capital Changes-20.9M0-18.9M20.6M-90.1M-48.1M50.1M-20.8M-34.8M-25M-2.8M-1.4M-200K-29.7M-18.8M-43.3M-9.2M73.7M-16.1M-14.1M-18.6M-10M-3.7M600K9.3M-20.2M28.3M-15.6M107.6M
Change in Receivables-5.6M04.3M-12.6M-55.5M-31.4M10.1M-18.2M-45.7M-83.2M-6M13.6M-900K-1.4M-14.1M-15.3M4.6M1.7M2.3M-14.5M-11.1M-2.2M0000000
Change in Inventory-9.7M0-11.8M83M-98.5M-62M25.5M2.4M-42.2M-30.8M7.7M5.5M-11.1M-10.1M-1M-14.3M-2.3M18.9M-8.6M-12M-21M-20.3M-11.3M2.2M3.5M4.3M4.7M31.6M-5.7M
Change in Payables-17.7M0-4.5M-26.9M54.2M90.2M-45.9M038.4M48.6M-3.4M-24.5M500K-4.4M-5.5M-13.7M-11.5M-9.8M-9.8M12.4M-7.4M3M0000000
Cash from Investing-72M-75.1M-62M-111.8M-42.1M-36.2M-29.7M-31M-35.5M-29.6M-209.1M15M-119M-116.1M-70.3M-10.1M-8.6M-7.2M-7.8M-40.6M4.6M-27.8M-89.4M-19.4M-51.8M-78M-10.7M-3M-48.9M
Capital Expenditures-62.5M-50.3M-62.3M-77.2M-42.3M-39.1M-29.7M-29.9M-30.1M-32.2M-16.5M-26.2M-21.9M-20.5M-17.3M-10.1M-8.8M-7.2M-9.1M-40.6M-7.6M-8.3M-9.6M-7.8M-11.4M-8.4M-6.6M-8.4M-49.9M
CapEx % of Revenue3.49%2.83%3.38%3.96%2.15%2.64%2.49%1.98%2.04%2.46%1.87%2.59%2.28%2.5%2.23%1.3%1.29%1.2%1.42%6.74%1.43%1.57%2%1.69%2.52%2%1.56%1.63%10.73%
Acquisitions1.6M-700K-200K-34.7M2M3M100K0-5.4M2.6M-197.4M41.5M-98.7M-94.4M-53.1M7.6M13M0000-22.3M-80.2M-6M-5.8M-59.1M000
Investments-----------------------------
Other Investing-11.1M-24.1M500K100K-1.8M-100K-100K-1.1M-1.2M-8.9M-16.5M32.6M-6.8M100K200K-7M-8.6M1.3M1.3M-28.4M9.6M2.8M400K-5.6M-34.6M-10.5M-4.1M5.4M1M
Cash from Financing-68M-63.9M-35.3M-39M-33.7M-20M-86.8M-177.9M-36.2M-66.4M70.5M-36.3M-24.3M112.8M-44.7M-55M-6.5M-26.6M-17M-85.1M-7.4M15.5M8.3M-53.2M-74M-600K-114.9M-80.8M-196.1M
Debt Issued (Net)000-2.3M-100K-600K-61.1M-150.2M-14.2M-53.5M135.7M-6.4M-4.7M121.8M0-27M-4M-25.7M-8.4M-67.1M7.8M20.3M12M-51.9M-72M18.3M-103.3M-77.5M300.8M
Equity Issued (Net)-26M01.4M-200K-3.7M9.3M100K-2.4M-300K5.7M-6.3M-14.3M-6.5M100K-200K-27.4M-2.5M200K-8.6M-15.9M-12.6M-1.1M-1.7M1.7M0-3M-13.6M-5.7M-13.2M
Dividends Paid-42.4M-42.4M-38.8M-35.1M-31.7M-28.8M-25.6M-25M-21.7M-18.6M-15.9M-14.9M-13.4M-12M-46.7M00-1.2M-2.4M-2.2M-1.9M-1.7M-1.5M-600K-600K0000
Share Repurchases-26.2M0-700K-1.1M-5.9M-800K-2.1M-2.4M-1.4M-1.1M-8.4M-15.3M-6.9M-3.7M-1.4M-28.1M-2.7M0-10.5M-20M-15.6M-2.5M-4.5M-1.2M-200K-4M-13.6M-5.7M-13.2M
Other Financing400K-21.5M2.1M-1.4M1.8M100K-200K-300K00-43M-1.2M300K2.9M2.2M-600K0100K2.4M100K-700K-2M-500K-2.4M-1.4M-15.9M2M2.4M-483.7M
Net Change in Cash-10.7M3.3M85.5M56.6M5.3M36.5M29.6M-47.4M32.9M-11.7M-35M95.3M-38.6M57.8M-53.8M-30.3M42.7M54.7M-10.4M-77.6M33M35.6M-12.8M19.4M-20.3M5.3M500K10.7M-3.2M
Free Cash Flow76.8M88M143.1M145.2M39.4M54.1M116.2M131.7M74.8M50.5M88M91.5M84.4M40.8M44M24.6M49.4M80.2M5.3M7.3M28.8M35.5M52.8M77.4M88.6M81.6M127.4M100.3M188.4M
FCF Margin %4.29%4.95%7.75%7.45%2.01%3.65%9.74%8.7%5.06%3.86%9.96%9.04%8.78%4.98%5.67%3.18%7.23%13.4%0.83%1.21%5.41%6.73%10.99%16.75%19.62%19.39%30.16%19.41%40.52%
FCF Growth %-9%-38.5%-1.45%268.53%-27.17%-53.44%-11.77%76.07%48.12%-42.61%-3.83%8.41%106.86%-7.27%78.86%-50.2%-38.4%1413.21%-27.4%-74.65%-18.87%-32.77%-31.78%-12.64%8.58%-35.95%27.02%-46.76%-
FCF per Share3.093.525.705.801.582.184.695.333.042.063.603.723.391.691.841.001.993.250.220.291.141.442.033.083.533.284.903.596.49
FCF Conversion (FCF/Net Income)0.67x1.19x5.18x1.49x0.61x1.00x5.08x1.44x1.23x1.34x1.29x0.98x1.26x0.79x0.90x0.71x0.79x13.66x1.15x1.62x3.19x-0.35x10.06x1.64x1.92x16.07x7.32x2.55x3.38x
Interest Paid00000004.8M000000000000000000000
Taxes Paid00000000000000000000000000000

Key Metrics

Growth RegimeMixed
ProfitabilityModerate
Balance SheetFortress
Cash FlowMixed
Top Statement Risk

Working Capital Volatility

Verified Source

Metrics are mathematically derived from official filings.

SEC 10-K (2026Q1)

Earnings Quality and Cash Conversion

As reported in recent financial filings, Innospec's operating cash flow to net income ratio has exhibited extreme volatility, ranging from a low of 0.15 in 2024Q2 to a high of 3.05 in 2025Q3, indicating that reported earnings are frequently decoupled from actual cash generation.

The significant variance between net income and operating cash flow suggests that non-cash charges and accounting adjustments, likely related to legacy environmental liabilities, frequently distort the company's true cash-generating capacity. Investors should monitor this divergence closely, as it implies that net income may not be a reliable proxy for the company's ability to fund operations or capital expenditures.

Free Cash Flow Margin Instability

Based on quarterly cash flow statements, Innospec's free cash flow margins have fluctuated wildly, swinging from a peak of 14.8% in 2024Q3 to negative territory in 2025Q2, highlighting a lack of consistent cash flow conversion despite the company's specialized product portfolio and market positioning.

This erratic trajectory suggests that the company's cash flow is highly sensitive to cyclical shifts in its oilfield services segment and periodic working capital swings. The inability to maintain a stable FCF margin warrants further investigation into whether the business model is inherently capital-intensive or if operational inefficiencies are periodically suppressing cash conversion.

Working Capital Cycles Impede Liquidity

According to historical cash flow data, working capital changes have been a major source of cash flow volatility, with quarterly swings as large as $26 million in 2024Q1, reflecting the challenges of managing inventory and receivables across diverse specialty chemical and oilfield service end-markets.

The frequent shifts between cash inflows and outflows from working capital suggest that the company's cash cycle is highly susceptible to fluctuations in raw material costs and customer payment timing. This volatility complicates cash flow forecasting and may indicate that the company is struggling to optimize its inventory levels relative to shifting demand patterns.

Conservative Capital Allocation Strategy

As evidenced by the company's financial statements, Innospec maintains a substantial cash position while prioritizing modest share repurchases and dividends, with $7.1 million allocated to buybacks in 2026Q1, reflecting a cautious approach to capital deployment that may be limiting potential return on equity.

The company's preference for maintaining a large cash balance rather than pursuing aggressive growth or higher shareholder returns suggests a defensive posture, likely influenced by the need to fund legacy environmental remediation. While this provides a safety buffer, it may also indicate a lack of high-conviction investment opportunities that meet the company's internal return thresholds.

IOSP — Frequently Asked Questions

Quick answers to the most common questions about buying IOSP stock.

How much cash does Innospec Inc. (IOSP) generate from operations?

Innospec Inc. (IOSP) generated $138.3M in net cash from operating activities in 2025. This reflects the cash generated directly from core business operations.

What is Innospec Inc.'s free cash flow?

Innospec Inc. (IOSP) generated $88.0M in free cash flow in 2025. Free cash flow is the cash left over after capital expenditures, which can be used to pay dividends, repurchase shares, or pay down debt.

What is Innospec Inc.'s capital expenditure (CapEx)?

Innospec Inc. (IOSP) spent $50.3M on capital expenditures in 2025. CapEx represents the cash invested in physical assets like property, plant, and equipment to maintain or grow the business.

How does Innospec Inc. distribute cash to shareholders?

In 2025, Innospec Inc. (IOSP) returned $42.4M to shareholders via cash dividends. This shows the company's commitment to returning capital to its equity investors.